ARTICLES BY THIS AUTHOR
- 5/21/2020
Hikma gets FDA green light for generic Vascepa
Hikma’s generic Vascepa capsules will be available in 1-gram dosage strength. - 5/21/2020
Mayne Pharma launches BAC capsules
Butalbital, acetaminophen and caffeine capsules had a market value of roughly $40 million for the 12 months ended March 31, 2020, according to IQVIA. - 5/20/2020
Cipla gets FDA nod for generic Migranal
Migranal and its authorized generic equivalents had a market value of roughly $102 million for the 12 months ended March 2020, according to IQVIA. - 5/20/2020
Schnucks to debut EatWell store format
EatWell, A Natural Food Store by Schnucks, will open in early summer 2020 in Columbia, Mo. - 5/20/2020
Akorn files for bankruptcy
Akorn said it will continue to operate as usual throughout the duration of the Chapter 11 and sale process, including meeting its contractual obligations and making payments to vendors. - 5/19/2020
Industry orgs hail HHS guidance enabling pharmacists to tests for COVID-19
The Department of Health and Human Services Guidance allows pharmacists to order and administer FDA-approved COVID-19 tests, superseding any state-level barriers to doing so. - 5/19/2020
AllianceRx Walgreens Prime to distribute Lundbeck's Vyepti
AllianceRx Walgreens Prime will distribute Lundbeck's Vyepti, an intravenous preventive migraine treatment. - 5/19/2020
McKesson posts strong Q4, fiscal year results
McKesson’s pharmaceutical and specialty solutions segment saw revenue increase 13% over Q4 2019, totaling $46.3 billion, and full-year revenue for the segment rose 9% over the prior fiscal year, totaling $183.3 billion. - 5/18/2020
NACDS praises Maryland e-prescribing law to help prevent opioid abuse
Maryland's House Bill 512/Senate Bill 1666 requires e-prescribing of controlled substances by Jan. 1, 2022. - 5/18/2020
FDA gives tentative nod for Zydus Cadila's generic Northera
Zydus Cadila’s droxidopa capsules will be available in dosage strengths of 100 mg, 200 mg, and 300 mg.